MedTrace Logo

Probiotics for Prevention of Antibiotic-associated Diarrhea

NCT00641199 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 204

Last updated 2010-01-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate if ingestion of a probiotic formula (Jarrow-Dophilus EPS)reduces incidence of diarrhea and improves the quality of life of patients receiving antibiotic therapy.

Conditions

  • Antibiotic-Associated Diarrhea

Interventions

OTHER

Jarro-Dophilus EPS probiotics

Jarro-Dophilus EPS product 2 capsules twice daily. 4.4 billion live bacteria per capsule.

Sponsors & Collaborators

  • Jarrow Formulas Inc

    collaborator INDUSTRY

  • Institut Rosell

    collaborator OTHER

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Yvonne M Shevchuk, B.S.P., Pharm D. · College of Pharmacy and Nutrition, University of Saskatchewan

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00641199 on ClinicalTrials.gov